Dr. Fathi graduated from Rutgers University (Ph.D. and Post-Doctoral Fellow) and Texas Tech University (BSc).
Prior to joining RedHill, Dr. Fathi served as Director of Research Operations at XTL Biopharmaceuticals. He was previously at VivoQuest, PharmaGenics, Metrigen, Enzo Biochem and the Harvard Institute of Chemistry and Cell Biology.